Charlie Hospital Semarang Tbk. vs Reksa Dana Indeks Mandiri ETF LQ45 — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Reksa Dana Indeks Mandiri ETF LQ45 trades at Rp732 (market cap 9.25B, 100 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 80.2× Reksa Dana Indeks Mandiri ETF LQ45's market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 100). Which is the better fit depends on your goals.
| RSCH | XMLF | |
|---|---|---|
Market Cap | 742B | 9.25B |
Volume | 29.45M | 100 |
Lot | 294.49K | 1 |
Turnover | 8.14B | 73.2K |
Average Price | 276.35 | 732 |
Value | 8.14B | 73.2K |
Indicative Equilibrium Price | 270 | — |
Indicative Equilibrium Volume | 103 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →